The roles of T helper type 17/regulatory T cells in acute rejection after liver transplantation in rats

Transplantation

Volumn 99, Issue 6, 2015, Pages 1126-1131

  Zhou, Yaxing ^a   Yang, Xiaojun ^b   Zhang, Hai ^c   Jiang, Jianguo ^a  

^a NANTONG UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CD4+ CD25+ T LYMPHOCYTE; CELL ASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; GRAFT SURVIVAL; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MALE; MOLECULAR DYNAMICS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RAT; REGULATORY T LYMPHOCYTE; SURVIVAL RATE; SURVIVAL TIME; TH17 CELL; ACUTE DISEASE; ADVERSE EFFECTS; ALLOGRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; GRAFT REJECTION; IMMUNOLOGY; TRANSPLANTATION TOLERANCE; WISTAR RAT;

ACUTE DISEASE; ALLOGRAFTS; ANIMALS; ANTIBODIES, NEUTRALIZING; GRAFT REJECTION; INTERLEUKIN-10; INTERLEUKIN-17; LIVER TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; RATS; RATS, WISTAR; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION TOLERANCE;

EID: 84930526116     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000666     Document Type: Article

References (32)

1. Hoti E, Levesque E, Sebagh M, et al. Liver Transplantation with grafts from donors who die from suicide by hanging: A matched cohort study. Transplantation 2014;98:1236-43.
2. Auzinger G, Willars C, Loveridge R, et al. Extracorporeal membrane oxygenation for refractory hypoxemia after liver transplantation in severe hepatopulmonary syndrome: A solution with pitfalls. Liver Transplant 2014.
3. Senkerikova R, Frankova S, Sperl J, et al. Incidental hepatocellular carcinoma: risk factors and long-term outcome after liver transplantation. Transplant Proc 2014;46(5):1426.
4. Mukhtar A, Abdelaal A, Hussein M, et al. Infection complications and pattern of bacterial resistance in living-donor liver transplantation: A multicenter epidemiologic study in Egypt. Transplant Proc 2014;46(5): 1444.
5. Joffre O, Santolaria T, Calise D, et al. Prevention of acute and chronic allograft rejection with CD4 + CD25 + Foxp3+ regulatory T lymphocytes. Nat Med 2008;14(1):88.
6. Rocha PN, Plumb TJ, Crowley SD, Coffman TM. Effector mechanisms in transplant rejection. Immunol Rev 2003;196: 51.
7. Xiang Z, Ma LL, Manicassamy S, et al. CD4+ T cells are sufficient to elicit allograft rejection and major histocompatibility complex class I molecule is required to induce recurrent autoimmune diabetes after pancreas transplantation in mice. Transplantation 2008;85(8):1205.
8. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008;453(7198):1051.
9. McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity 2008;28(4):445.
10. Yang J, Chu Y, Yang X, et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009;60(5):1472.
11. Mitchell P, Afzali B, Lombardi G, Lechler RI. The T helper 17-regulatory T cell axis in transplant rejection and tolerance. Curr Opin Organ Transplant 2009;14(4):326.
12. Crispim JC, Grespan R, Martelli-Palomino G, et al. Interleukin-17 and kidney allograft outcome. Transplant Proc 2009;41(5):1562.
13. Fabrega E, Lopez-Hoyos M, San Segundo D, Casafont F, Pons-Romero F. Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation. Liver Transplant 2009;15(6):629.
14. Loong CC, Hsieh HG, Lui WY, Chen A, Lin CY. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 2002;197(3):322.
15. Hsieh HG, Loong CC, Lui WY, Chen A, Lin CY. IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transpl Int 2001;14(5):287.
16. He Q, Fan H, Li JQ, Qi HZ. Decreased circulating CD4 + CD25highFoxp3+ T cells during acute rejection in liver transplant patients. Transplant Proc 2011;43(5):1696.
17. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997;25(3):658.
18. Wen X, He L, Chi Y, et al. Dynamics of Th17 cells and their role in Schistosoma japonicum infection in C57BL/6 mice. PLoS Negl Trop Dis 5(11):e1399.
19. Duan L, Wang CY, Chen J, et al. High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response. Lab Invest 2011;91(1):43.
20. Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol 2010;40(7):1830.
21. Itoh S, Kimura N, Axtell RC, et al. Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion. Circulation 2011;124(11 Suppl):S187.
22. Karczewski J, Karczewski M, Glyda M, Wiktorowicz K. Role of TH1/ TH2 cytokines in kidney allograft rejection. Transplant Proc 2008;40(10):3390.
23. San Segundo D, Lopez-Hoyos M, Fernandez-Fresnedo G, et al. T(H)17 versus Treg cells in renal transplant candidates: effect of a previous transplant. Transplant Proc 2008;40(9):2885.
24. Wang Y, Zhang M, Liu ZW, et al. The ratio of circulating regulatory T cells(tregs)/th17 cells is associated with acute allograft rejection in liver transplantation. PLoS One 2014;9(11):e112135.
25. Xie XJ, Ye YF, Zhou L, et al. Th17 promotes acute rejection following liver transplantation in rats. J Zhejiang Univ Sci B 2010;11(11):819.
26. Vokaer B, Van Rompaey N, Lemaitre PH, et al. Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection. J Immunol 2010;185(6):3417.
27. Antonysamy MA, Fanslow WC, Fu F, et al. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol 1999;162(1):577.
28. Fan L, Benson HL, Vittal R, et al. Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation. Am J Transplant 2011;11(5):911.
29. Itoh S, Nakae S, Axtell RC, et al. IL-17 contributes to the development of chronic rejection in a murine heart transplant model. J Clin Immunol 2010;30(2):235.
30. Shilling RA, Wilkes DS. Role of Th17 cells and IL-17 in lung transplant rejection. Semin Immunopathol 2011;33(2):129.
31. Loverre A, Tataranni T, Castellano G, et al. IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection. Am J Transplant. 2011;11(6):1248.
32. Antonysamy MA, Fanslow WC, Fu F, et al. Evidence for a role of IL-17 in alloimmunity: A novel IL-17 antagonist promotes heart graft survival. Transplant Proc 1999;31(1-2):93.